All In Biotech

Drug Trial Radar · NCT00200343

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

A 24-week Multicenter Double-blind Control Trial With Ursodeoxycholic Acid in Patients With Chronic Hepatitis C

Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 596 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

596

Actual

Start

Jul 2002

Primary completion

Not stated

Study completion Dec 2004

Sponsor

Lead sponsor
Tanabe Pharma CorporationIndustry
Sponsor type
Industry
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a 24-week multicenter, randomized, double-blind control trial with ursodeoxycholic acid (UDCA) in patients with chronic hepatitis C in Japan. The primary objectives of this study are to verify the superiority of efficacy of UDCA 600 or 900mg/day to that of 150mg/day and the safety of UDCA treatment.

Conditions

  • Chronic Hepatitis C

Interventions

  • Ursodeoxycholic acid 150mg / dayDrug

    Ursodeoxycholic acid, 150mg/ day, three times a day at meals

  • Ursodeoxycholic acid 600mg / dayDrug

    Ursodeoxycholic acid, 600mg/ day, three times a day at meals

  • Ursodeoxycholic acid 900mg / dayDrug

    Ursodeoxycholic acid, 900mg/ day, three times a day at meals

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Alanine Aminotransferase at BaselineTime frame: 0 week
  2. Percentage Change of Alanine Aminotransferase From Baseline at Week 24Time frame: 24 weeks (from baseline to Week 24)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Gastroenterology, University of Tokyo

    Hongo, Bunkyo-ku, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.